Proteomics in bone research
- PMID: 20121480
- PMCID: PMC2848984
- DOI: 10.1586/epr.09.90
Proteomics in bone research
Abstract
Osteoporosis is prevalent among the elderly and is a major cause of bone fracture in this population. Bone integrity is maintained by the dynamic processes of bone resorption and bone formation (bone remodeling). Osteoporosis results when there is an imbalance of the two counteracting processes. Bone mineral density, measured by dual-energy x-ray absorptiometry has been the primary method to assess fracture risk for decades. Recent studies demonstrated that measurement of bone turnover markers allows for a dynamic assessment of bone remodeling, while imaging techniques, such as dual-energy x-ray absorptiometry, do not. The application of proteomics has permitted discoveries of new, sensitive, bone turnover markers, which provide unique information for clinical diagnosis and treatment of patients with bone diseases. This review summarizes the recent findings of proteomic studies on bone diseases, properties of mesenchymal stem cells with high expansion rates and osteoblast and osteoclast differentiation, with emphasis on the role of quantitative proteomics in the study of signaling dynamics, biomarkers and discovery of therapeutic targets.
Figures


References
-
- Rodan GA. Bone mass homeostasis and bisphosphonate action. Bone. 1997;20:1–4. - PubMed
-
- Raisz LG, Rodan GA. Pathogenesis of osteoporosis. Endocrinol Metab Clin North Am. 2003;32:15–24. - PubMed
-
- Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med. 1993;94:646–650. - PubMed
-
- Melton LJ., 3rd How many women have osteoporosis now? J Bone Miner Res. 1995;10:175–177. - PubMed
-
- Advisory Group on Osteoporosis. Report. Department of Health; London, UK: 1994.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical